Delivery Order SPE2DB22D3011-SPE2DB23FP9LF
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a $1,756.20 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, which does not have a set-aside designation, is for the supply of 4564736964 ! MENQUADFI VIAL 0.5ML medical products. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this IDC,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,903.12 firm fixed-price contract is for the delivery of MENQUADFI VIAL 0.5ML medical supplies. It is an order under Amerisourcebergen's existing $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,115.52 firm fixed price delivery order is for the provision of MENQUADFI VIAL 0.5ML pharmaceutical products. The contract has an ultimate completion date of April 25, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The contract, valued at $1,493.23, is for the supply of pharmaceutical product MENQUADFI VIAL 0.5ML. There is no set-aside designation for the contract. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military treatment facilities, veterans'...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $22,690.64 award is for the supply of MENQUADFI VIAL 0.5ML pharmaceutical products. The delivery order has an ultimate completion date of August 9, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds several indefinite delivery contracts (IDCs) with DLA Troop Support Medical and the Department of Justice Federal Bureau of...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $10,886.55, is for the delivery of MENQUADFI VIAL 0.5ML medical supplies. The contract is a Firm Fixed Price Delivery Order with a completion date of December 6, 2024. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,281.73 firm fixed-price delivery order contract is for the supply of MENQUADFI VIAL 0.5ML medical products, with a completion date of July 15, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a substantial Indefinite Delivery Contract (IDC)...
- This firm-fixed-price delivery order with a ceiling value of $1,894.03 was awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The order is for the supply of MENQUADFI VIAL 0.5ML medical products, with a completion date of September 12, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025 for delivering a...
- This federal contract award is for the delivery of MENQUADFI VIAL 0.5ML medical products to the Defense Logistics Agency (DLA) by Amerisourcebergen Drug Corp's Corporate Office Division. The $1,756.20 firm fixed price delivery order was placed under Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to the Department of...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $5,268.60 firm fixed-price contract is for the supply of "MENQUADFI VIAL 0.5ML," a pharmaceutical product. The contract has an ultimate completion date of September 4, 2024. Amerisourcebergen is a large pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB23FP9LFDelivery Order
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. It is a $84,391.76 Firm Fixed Price Delivery Order for the procurement of MENQUADFI VIAL 0.5ML medical supplies. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order is a call against that larger IDC contract. Amerisourcebergen also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $84.4k | 2/16/23 |